Van Hulzen Asset Management’s Sabra Healthcare REIT, Inc. 7.125% Preferred Series A SBRAP Stock Holding History

Van Hulzen Asset Management’s Portfolio SBRAP Stock Details SBRAP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-18,334	Closed	-$492K	–	173
2016 Q3	$492K	Hold	18,334	–	–	0.27%	75
2016 Q2	$480K	Sell	18,334 -800	-4%	-$21K	0.27%	76
2016 Q1	$493K	Sell	19,134 -800	-4%	-$20.4K	0.28%	73
2015 Q4	$503K	Buy	19,934 +8,200	+70%	+$208K	0.31%	70
2015 Q3	$301K	Hold	11,734	–	–	0.19%	87
2015 Q2	$302K	Buy	11,734 +800	+7%	+$21.1K	0.16%	107
2015 Q1	$293K	Buy	+10,934	New	+$295K	0.18%	105

Van Hulzen Asset Management's SBRAP Position: Q4 2016 in Review

Van Hulzen Asset Management sold out of Sabra Healthcare REIT, Inc. 7.125% Preferred Series A (SBRAP) in Q4 2016, closing a stake of 18,334 shares — an estimated $492K sold.

Van Hulzen Asset Management first reported a position in SBRAP in Q1 2015 and held it in 7 quarters. The position peaked at $503K in Q4 2015. 0 funds tracked by Wall St. Rank hold SBRAP as of Q4 2016.

Van Hulzen Asset Management reported no remaining Sabra Healthcare REIT, Inc. 7.125% Preferred Series A position as of Q4 2016 after selling out during the quarter.
Van Hulzen Asset Management sold 18,334 Sabra Healthcare REIT, Inc. 7.125% Preferred Series A shares in Q4 2016, an estimated $492K.
Van Hulzen Asset Management first reported a position in Sabra Healthcare REIT, Inc. 7.125% Preferred Series A in Q1 2015 and held it in 7 quarters.
Van Hulzen Asset Management's Sabra Healthcare REIT, Inc. 7.125% Preferred Series A position peaked at $503K in Q4 2015.
0 funds tracked by Wall St. Rank held Sabra Healthcare REIT, Inc. 7.125% Preferred Series A as of Q4 2016.

Based on Van Hulzen Asset Management's 13F filing for Q4 2016, filed 6 Feb 2017.